Asset Details
Do you wish to reserve the book?
Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer
Do you wish to request the book?
Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer
2016
Overview
Tumor cells exhibit unique metabolic adaptations that are increasingly viewed as potential targets for novel and specific cancer therapies. Among these targets, the carnitine palmitoyltransferase system is responsible for delivering the long-chain fatty acid (FA) from cytoplasm into mitochondria for oxidation, where carnitine palmitoyltransferase I (CPTI) catalyzes the rate-limiting step of fatty acid oxidation (FAO). With increasing understanding of the crucial role had by fatty acid oxidation in cancer, CPTI has received renewed attention as a pivotal mediator in cancer metabolic mechanism. CPTI activates FAO and fuels cancer growth via ATP and NADPH production, constituting an essential part of cancer metabolism adaptation. Moreover, CPTI also functionally intertwines with other key pathways and factors to regulate gene expression and apoptosis of cancer cell. Here, we summarize recent findings and update the current understanding of FAO and CPTI in cancer and provide theoretical basis for this enzyme as an emerging potential molecular target in cancer therapeutic intervention.
Publisher
Nature Publishing Group UK,Springer Nature B.V,Nature Publishing Group
Subject
/ 96/95
/ Adenosine Triphosphate - antagonists & inhibitors
/ Adenosine Triphosphate - biosynthesis
/ Antineoplastic Agents - pharmacology
/ Biomedical and Life Sciences
/ Cancer
/ Carnitine - analogs & derivatives
/ Carnitine O-Palmitoyltransferase - antagonists & inhibitors
/ Carnitine O-Palmitoyltransferase - genetics
/ Carnitine O-Palmitoyltransferase - metabolism
/ Fatty Acids - antagonists & inhibitors
/ Gene Expression Regulation, Neoplastic
/ Humans
/ Isoenzymes - antagonists & inhibitors
/ Lipid Metabolism - drug effects
/ NADP - antagonists & inhibitors
/ Review
/ Tumors
